Pain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD

Similar documents
Equianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Intractable pain syndrome is defined as persistent pain despite all the reasonable efforts to treat.

Overview of Essentials of Pain Management. Updated 11/2016

Opioid Pearls and Acute Pain Management

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST

(30689) PROT Pain PCA Adult Patient Controlled Analgesia

4/3/2018. Management of Acute Pain Crises. Five Mistakes I ve made and why you shouldn t

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

What to do when you are called to see a patient with... PAIN. Susan Merel, MD Division of General Internal Medicine July 2018

Agenda. Case Discussions. Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT. Daniel Alford, MD Disclosures

1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective

Pain and the MGH Promise

Fighting the Good Fight: How to Convert Opioids Just Right!

Pain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine

Pharmacologic Considerations for Managing Sickle Cell Pain Claire Saadeh, PharmD, BCOP May 5, 2015

Optimizing Your Quality of Life During Cancer Treatment: Pain & Side Effect Management

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

Opioid Case Studies. Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN. September 29, MFMER slide-1

Use of PCA devices in Difficult Populations

Opioid Conversions Mixture of Science and Art

Pain Management in Hospice and Palliative Care

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

Opioids in Serious Medical Illness

PAIN MANAGEMENT PGY-1. Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline

OPIOID- INDUCED NEUROTOXICITY*

Opioid use in older adults Is it a good idea? Regional Geriatric Rounds April 26, 2013

Analgesics: Management of Pain In the Elderly Handout Package

Opioid Use in Serious Illness

Long Term Care Formulary HCD - 08

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

Opioid Rotation. Dr Bruno Gagnon, M.D., M.Sc.

10 mg hydrocodone equals how much oxycodone

BASICS OF OPIOID PRESCRIBING 10:30-11:45AM

PEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.

Pain Management Dilemmas. Five Pain Dilemmas. Barriers: Meet Loretta. Daniel Johnson, MD, FAAHPM

PEDIATRIC SPINE SURGERY POST-OP PLAN - Phase: Pediatric Spine Surgery General Orders

Update on Pain: Collaborative Care for the Complex Patient

Pain Management Strategies Webinar/Teleconference

Managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder

Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center

Methadone Maintenance

STARSHIP WITHDRAWAL OF ANALGESIA AND SEDATION

Attach patient label here. Physician Orders ADULT: Palliative Care Plan

Session II. Learning Objectives for Session II. Key Principles of Safe Prescribing. Benefits and Limitations of ER/LA Opioids

ANSWER # 1 PHARMACOLOGY. Methadone answers Stoltzfus 4/5/2012 METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017

Review of Pain Management with Clinical and Regulatory Updates

Objectives: What is your Definition of Pain? 8/16/2017

UMC Health System Patient Label Here. PHYSICIAN ORDERS Diagnosis

@FeliciaJCox. Caring for the person with addiction in the acute pain setting. Felicia Cox FRCN MSc RN

2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio (740) ~

Palliative Prescribing - Pain

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Approach to Acute Pain Management

Objectives. Patient Controlled Analgesia (PCA) Management in the Seriously Ill. Discuss principles for opioid dosing and titration for acute pain

Cancer Pain: A Clinical Overview. Linda A. King, MD Section of Palliative Care and Medical Ethics

Opioid Pain Management. John Manfredonia, DO. Disclosures. Dr. Manfredonia discloses his employment as Regional Medical Director for VistaCare

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

Waterloo Wellington (WW) Symptom Management Guideline for the End of Life (EOL) Medication Order Set for Long Term Care (LTC)

Opioid overdose versus opioid toxicity. Dr Colette Reid

UMC Health System Patient Label Here PHYSICIAN ORDERS

OAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM

Tips for Managing Acute Pain

Buprenorphine pharmacology

UCSF: 150 years in the making

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Pain Management in the Hospital

Acute Pain NETP: SEPTEMBER 2013 COHORT

Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45

Tapering Opioids Best Practices*

Demystifying Opioid Conversion Calculations

Acute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017

RELIEVING VIRGINIA S PAIN AND SUFFERING 3:45-4:45PM

Intraspinal (Neuraxial) Analgesia Community Nurses Competency Test

Palliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015

Steven Prakken MD Chief, Medical Pain Service Duke Pain Medicine

Assessment. Consults & Referrals

Palliative Emergencies. Ken Stakiw

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Disclosures: These presenters have no financial relationships with commercial interests.

Opioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms:

Dose equivalent of fentanyl patch to oxycontin

OPIOID MANAGEMENT. Caroline Ha MD. Assistant Professor of Palliative Medicine

Multiple Choice Questions

Management of Cancer Pain

Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Medications for the Treatment of Neuropathic Pain

Analgesia is a labeled indication for all of the approved drugs I will be discussing.

morphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice

Managing Pain in the Patient with Opioid Use Disorder: Inpatient Management. Melissa Weimer, DO, MCR Oregon Health & Science University

CLINICAL GUIDELINES FOR END OF LIFE CARE MEDICATIONS IN LONG TERM CARE HOMES

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

Disclosures. Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals

Opioids Research to Practice

Transcription:

Pain management Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD

Case #1 61 yo man with history of Stage 3 colon cancer, s/p resection and adjuvant chemotherapy with FOLFOX now in remission. 8 years later, presented with right sided chest pain and weight loss.

Adenocarcinoma

Started on chemotherapy (Carboplatin/Pemetrexed) Developed progressive chest pain, respirophasic upper back pain and dyspnea. Meds uptitrated by Oncologist in consultation with pain service Return to ED 3 months after initiation of chemotherapy with severe, uncontrolled pain despite treatment at home. Repeat CT.

Meds: Fentanyl patch 100mcg/hr q72h Hydromorphone 4mg PO Q3h PRN Gabapentin 600mg PO TID Docusate-senna 1 tab PO BID

He has been taking 2-3 of his hydromorphone tabs every 3 hours for the past 18 hours. Before meds: pain 20/10 After meds: pain 10/10 Spending most of time in bed, irritable, can t sleep, no appetite

Exam T: 99.3, HR 103, BP 125/81 Brow furrowed, uncomfortable appearing Tender to palpation over entire anterior chest wall; no masses Tachypneic, splinting respirations, decreased breath sounds over lower 1/3 of R lung field Rest benign

Acute pain crisis How do you treat this pain crisis? What do you do with his fentanyl? How do you administer the breakthrough meds? Bolus dosing PCA

What is this patient s 24 hour oral morphine equivalent (OME)?

Our patient Opioid usage Fentanyl 100mcg/hr 200mg oral morphine/24hr Hydromorphone 8mg (2 tabs) PO q3h x 6 (18 hours) 48mg PO hydromorphone 192 mg (48*4) oral morphine TOTAL USAGE: 392 mg oral morphine equivalent (OME)

What would you recommend as a starting bolus dose using IV morphine? IV hydromorphone? Dose: 10% of 24 hour usage

Acute pain crisis Opioid bolus algorithm Dose: 10% of 24 hour usage Starting bolus dose: 39.2 mg OME 13mg IV morphine 2mg IV hydromorphone Re-assess every 10-15 mins Rebolus if: Partial control: same dose (50% decrease if SEs) Partial control : decrease in VAS of 2 Uncontrolled (severe): increase by 50-100% Uncontrolled : no improvement in pain score

Our patient 11:00 AM: Given 2mg IV hydromorphone 11:20 AM: Pain 10/10 Given 4mg IV hydromorphone 11:35 AM: Pain 7/10 Given 4mg IV hydromorphone 11:55 AM: Pain 4/10 ( tolerable ); alert, no SEs

Maintenance regimen If you wanted to administer a round-the-clock, hydromoprphone bolus regimen to manage this patient s pain, what dose and frequency would you give? What would your breakthrough dose be?

Acute pain crisis Maintenance regimen: Bolus dosing + breakthrough Mild pain, no SEs (Total amount administered) q 4h + 0.1(Total 24-hour dose) q1h PRN No pain OR Ses 0.5(Total amount administered) q4h + 0.1(Total 24-hour dose) q1h PRN EXAMPLE: 10mg IV hydromorphone administered Order: 10mg IV hydromorphone q4h RTC 6mg IV hydromorphone q1h

Acute pain crisis Maintenance regimen: PCA What drip do you start? Medication? Dose/Rate? If you are going to give a bolus, what dose do you give? What is the demand dose? What is the frequency?

Comparing opioid drips Drug Potency Metabolites Cost* Morphine Active $ Hydromorphone Minimally active $$ Fentanyl Inactive $$ *Note that cost depends on doses used as PCAs are charged per unit

Based on your round-the-clock calculation, if you wanted to give this patient a hydromorphone drip, what dose would you choose?

Calculating drip rate Calculated total daily dose: Hydromorphone 10mg IV Q4h= 60mg/24h 60/24= IV hydromorphone 2.5mg/hr IV Morphine: ~15mg/hr (2.5*6) IV fentanyl: ~ 160mcg/hr (2.5/15)

Acute pain crisis Conversion to PCA If you stop the fentanyl, what drip do you start? Medication? Dose/Rate? What is the demand dose? What is the frequency?

If you wanted to convert this regimen to a hydromorphone PCA with a continuous infusion, what would your drip dose be? What would your demand dose be?

Acute pain crisis Opioid bolus Calculating the bolus dose 10% of 24 hour rate/hour 50-150% of basal rate EXAMPLE: IV hydromorphone 60mg/24hr Breakthrough=6mg/hr (1.5mg q15mins OR 1mg q10mins)

Case # 2 50 yo female, former heroin abuse admitted to hospital with increasing abdominal pain and early satiety Home medications: Methadone 60 mg po daily, Tylenol up to 8 grams/day, Aleve prn Pain history: vague, aching, located in mid epigastrum, radiates into her back, 10/10, wakes her up at night, some nausea when severe On exam, ill-appearing and cachetic, stable VS, abdominal is distended and painful to touch, non-tender spine, no fluid wave Labs: LFTs:AST/ALT 300/356, Cr 1.9 (unclear baseline)

CT: Metastatic pancreas cancer

Questions What options do you have to address her pain? Explain why or why not you would choose certain options. What do we do with the Methadone?

Acute pain management for patients on Opioid Agonist Therapy (OAT) for addiction Methadone Buprenorphine

Common misconceptions The OAT provides analgesia Use of opioids in these patients may result in addiction relapse Additive effects of opioid analgesics and OAT may cause respiratory and CNS depression The pain complaint may be drug-seeking

The truth OAT at once daily dosing to prevent withdrawal (24-48 hrs) not consistent with duration of action for analgesia (4-8 hrs) Opioid tolerance is real patients have less effect and for shorter duration when adding another opioid Opioid-hyperalgesia can occur - latent, due to neuro-plastic changes from long-term exposure Stress from uncontrolled pain more likely to cause relapse than treating the pain with an opioid Tolerance to side effects is high for patients on OAT OAT treatment blocks euphoric effect of other opioids

Recommendations - Methadone Continue usual dose of po methadone, but must verify dose with the program If patient cannot take po, give 50% in IV form and divide q 6 or q 8 (example: 60 mg po reduce to 30 mg IV, give 10 mg IV q 8) Add an opioid co-analgesic, higher doses and shorter interval of immediate release with continuous or scheduled dosing Long-acting opioids may cause less euphoric effects Notify methadone program upon discharge of new plan

Our patient Methadone and other home meds continued Celiac plexus block on admission: initially brought pain from 10/10 to 3/10, then increased two days later to 10/10 Steroids added decadron 8 mg po qam, plus PPI Started hydromorphone 1 mg IV q 2 which escalated to 2, then 3 mg IV q 2, switched to IV gtt at 2 mg/hr, with increasing pain, despite multiple boluses q 2 and increase in drip rate Question what could be going on?

Opioid induced hyperalgesia (OIH) Neuroplastic changes in the peripheral and CNS, sensitization of pronociceptive pathways Central glutaminergic system, NMDA Must be differentiated from tolerance which gets better with increase in opioid Exam often find diffuse, ill-defined pain outside of level of original pain source, allodynia Can mimic opioid withdrawal

Our patient Severe abdominal and back pain, 20/10, unable to obtain a comfortable position Renal function declined to 2.5 Non-contrast CT abd/pelvis and Xray no changes OIH leading diagnosis

OIH - Treatment Reduce dose of current opioid Opioid rotation (methadone most common) Hydration Select other medications with pain properties (SNRI) Ketamine -uncompetitive antagonist of the phencyclidine binding site of NMDA receptor -usually given in hospital via infusion -dissociative side effects

Our patient Reduced hydromorphone Hydration Interventional pain performed second block Once pain and renal function improved she was discharged on LA morphine and back to methadone program

Acute pain crisis Opioid side effects Nausea Haldol Sedation Methylphenidate?? Respiratory depression Diluted naloxone Urinary retention Pruritis Myoclonus Opioid induced hyperalgesia